159 related articles for article (PubMed ID: 24344017)
21. Predictors of survival after operation among patients with large cell neuroendocrine carcinoma of the lung.
Eichhorn F; Dienemann H; Muley T; Warth A; Hoffmann H
Ann Thorac Surg; 2015 Mar; 99(3):983-9. PubMed ID: 25596870
[TBL] [Abstract][Full Text] [Related]
22. Expression of Notch1 and Numb in small cell lung cancer.
Kikuchi H; Sakakibara-Konishi J; Furuta M; Yokouchi H; Nishihara H; Yamazaki S; Uramoto H; Tanaka F; Harada M; Akie K; Sugaya F; Fujita Y; Takamura K; Kojima T; Harada T; Higuchi M; Honjo O; Minami Y; Watanabe N; Oizumi S; Suzuki H; Ishida T; Dosaka-Akita H; Isobe H; Munakata M; Nishimura M
Oncotarget; 2017 Feb; 8(6):10348-10358. PubMed ID: 28060745
[TBL] [Abstract][Full Text] [Related]
23. Neuroendocrine marker staining pattern categorization of small-sized pulmonary large cell neuroendocrine carcinoma.
Minami K; Tanaka Y; Ogawa H; Jimbo N; Nishio W; Yoshimura M; Itoh T; Maniwa Y
Thorac Cancer; 2019 Nov; 10(11):2152-2160. PubMed ID: 31583856
[TBL] [Abstract][Full Text] [Related]
24. Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung: Implications for clinical practice.
Metro G; Ricciuti B; Chiari R; Baretti M; Falcinelli L; Giannarelli D; Sidoni A; Mountzios G; Crinò L; Bellezza G; Rebonato A; Ferolla P; Toschi L
Lung Cancer; 2016 May; 95():82-7. PubMed ID: 27040856
[TBL] [Abstract][Full Text] [Related]
25. Transthoracic needle biopsy in the diagnosis of large-cell neuroendocrine carcinoma of the lung.
Marmor S; Koren R; Halpern M; Herbert M; Rath-Wolfson L
Diagn Cytopathol; 2005 Oct; 33(4):238-43. PubMed ID: 16138368
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of loss of heterozygosity in large cell neuroendocrine carcinomas of the lung and small cell lung carcinomas.
Takeuchi T; Minami Y; Iijima T; Kameya T; Asamura H; Noguchi M
Pathol Int; 2006 Aug; 56(8):434-9. PubMed ID: 16872437
[TBL] [Abstract][Full Text] [Related]
27. Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.
Zhang JT; Li Y; Yan LX; Zhu ZF; Dong XR; Chu Q; Wu L; Zhang HM; Xu CW; Lin G; Yu ZY; Hu J; Zhu B; Wang HJ; Yang F; Song ZB; Han ZB; Li MX; Lin J; Wu YL; Wang JL; Zhong WZ
Lung Cancer; 2020 Jan; 139():118-123. PubMed ID: 31775086
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary large cell neuroendocrine carcinoma demonstrates high proliferative activity.
Iyoda A; Hiroshima K; Moriya Y; Mizobuchi T; Otsuji M; Sekine Y; Shibuya K; Iizasa T; Saitoh Y; Fujisawa T
Ann Thorac Surg; 2004 Jun; 77(6):1891-5; discussion 1895. PubMed ID: 15172230
[TBL] [Abstract][Full Text] [Related]
29. Surgical management of pulmonary large cell neuroendocrine carcinomas: a 10-year experience.
Fournel L; Falcoz PE; Alifano M; Charpentier MC; Boudaya MS; Magdeleinat P; Damotte D; Régnard JF
Eur J Cardiothorac Surg; 2013 Jan; 43(1):111-4. PubMed ID: 22529187
[TBL] [Abstract][Full Text] [Related]
30. Differential retinoblastoma and p16(INK4A) protein expression in neuroendocrine tumors of the lung.
Dosaka-Akita H; Cagle PT; Hiroumi H; Fujita M; Yamashita M; Sharma A; Kawakami Y; Benedict WF
Cancer; 2000 Feb; 88(3):550-6. PubMed ID: 10649246
[TBL] [Abstract][Full Text] [Related]
31. Surgical resection should be considered for stage I and II small cell carcinoma of the lung.
Weksler B; Nason KS; Shende M; Landreneau RJ; Pennathur A
Ann Thorac Surg; 2012 Sep; 94(3):889-93. PubMed ID: 22429675
[TBL] [Abstract][Full Text] [Related]
32. Significant high expression of cytokeratins 7, 8, 18, 19 in pulmonary large cell neuroendocrine carcinomas, compared to small cell lung carcinomas.
Nagashio R; Sato Y; Matsumoto T; Kageyama T; Satoh Y; Ryuge S; Masuda N; Jiang SX; Okayasu I
Pathol Int; 2010 Feb; 60(2):71-7. PubMed ID: 20398190
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung.
Morise M; Hishida T; Takahashi A; Yoshida J; Ohe Y; Nagai K; Ishii G
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2121-30. PubMed ID: 25963795
[TBL] [Abstract][Full Text] [Related]
34. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
[TBL] [Abstract][Full Text] [Related]
35. Expression of heat shock proteins HSP70 and HSP27 in primary non-small cell lung carcinomas. An immunohistochemical study.
Małusecka E; Zborek A; Krzyzowska-Gruca S; Krawczyk Z
Anticancer Res; 2001; 21(2A):1015-21. PubMed ID: 11396134
[TBL] [Abstract][Full Text] [Related]
36. Behaviour and survival of high-grade neuroendocrine carcinomas of the lung.
Naranjo Gómez JM; Gómez Román JJ
Respir Med; 2010 Dec; 104(12):1929-36. PubMed ID: 20810262
[TBL] [Abstract][Full Text] [Related]
37. [Prognosis of surgically treated large cell neuroendocrine carcinoma].
Matsuura N; Nakashima N; Igai H; Tarumi S; Chang SS; Misaki N; Liu D; Go T; Ishikawa S; Huang CL; Yokomise H
Kyobu Geka; 2011 Mar; 64(3):187-90. PubMed ID: 21404553
[TBL] [Abstract][Full Text] [Related]
38. A subset of small cell lung cancer with low neuroendocrine expression and good prognosis: a comparison study of surgical and inoperable cases with biopsy.
Hamanaka W; Motoi N; Ishikawa S; Ushijima M; Inamura K; Hatano S; Uehara H; Okumura S; Nakagawa K; Nishio M; Horai T; Aburatani H; Matsuura M; Iwasaki A; Ishikawa Y
Hum Pathol; 2014 May; 45(5):1045-56. PubMed ID: 24746210
[TBL] [Abstract][Full Text] [Related]
39. Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group†.
Filosso PL; Rena O; Guerrera F; Moreno Casado P; Sagan D; Raveglia F; Brunelli A; Welter S; Gust L; Pompili C; Casadio C; Bora G; Alvarez A; Zaluska W; Baisi A; Roesel C; Thomas PA;
Eur J Cardiothorac Surg; 2015 Jul; 48(1):55-64. PubMed ID: 25406425
[TBL] [Abstract][Full Text] [Related]
40. The diagnostic utility of zinc E-box 1 (ZEB1) transcription factor for identification of pulmonary sarcomatoid carcinoma in cytologic and surgical specimens.
Viswanathan K; Siddiqui MT; Borczuk AC
J Am Soc Cytopathol; 2020; 9(1):55-61. PubMed ID: 31677963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
